{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T12:19:27Z","timestamp":1788351567395,"version":"build-2803163510"},"reference-count":26,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"unspecified","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Health Service Cancer Programme","award":["Small Business Research Initiative grant no. 30691"],"award-info":[{"award-number":["Small Business Research Initiative grant no. 30691"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Qual"],"accepted":{"date-parts":[[2026,2,13]]},"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Robust evidence supports International Ovarian Tumour Analysis (IOTA)-Assessment of Different Neoplasias in the Adnexa (ADNEX) ultrasound triage at 10% threshold for ovarian cancer (OC) diagnosis to identify women for referral to tertiary gynaecological cancer centres for further management. The IOTA-ADNEX risk prediction model has superior sensitivity compared with the current standard of care triage, Risk of Malignancy Index (RMI-1), yet NHS adoption is limited. In our survey of British Gynaecological Cancer Society clinicians, only 30% (24\/79) currently follow an IOTA model, despite 80% (63\/79) supporting implementation. We evaluated IOTA-ADNEX implementation within two NHS one-stop clinics (OSC) for suspected OC, examining clinical outcomes alongside implementation barriers and facilitators.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Mixed-methods study conducted across two UK NHS hospitals between June 2023 and June 2025. Implementation outcomes were surgical intervention rates comparing IOTA-ADNEX-guided and retrospectively calculated RMI-based management using National Institute for Health and Care Excellence\/Royal College of Obstetricians and Gynaecologists thresholds and patient process metrics. 11 qualitative semi-structured interviews were conducted with NHS staff involved in OSC implementation and thematic analysis performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 334 patients, 42% (139) underwent same-day discharge. Using IOTA-ADNEX at a 10% threshold, 10% (32\/334) of patients underwent surgery under the general gynaecology and cancer unit team. In comparison, 30% (94\/334) would have undergone surgery under the same teams if RMI-based triage had been used. Five themes identified from qualitative analysis: organisational infrastructure, clinical decision-making, communication and pathway definition, professional collaboration and training support, and patient experience. Key facilitators included dedicated clinical leadership, timely decision-making capabilities and quality assurance sessions. Barriers included lack of standardised post-clinic pathways and insufficient staff communication about pathway changes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>IOTA-ADNEX implementation in OSC offers high same-day discharge rates and reduction in surgical rates compared with RMI triage. To ensure success, implementation should be supported by adequate infrastructure, training and clear pathways. It requires leadership, comprehensive staff training and robust communication strategies. These findings provide practical guidance for healthcare systems for wider implementation of IOTA-ADNEX.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjoq-2025-003909","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T14:45:25Z","timestamp":1776696325000},"page":"e003909","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Mixed-methods evaluation of the implementation of IOTA-ADNEX ultrasound triage in NHS secondary care ovarian diagnostic one-stop clinics"],"prefix":"10.1136","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-5633-9136","authenticated-orcid":false,"given":"Vivian","family":"Do","sequence":"first","affiliation":[{"name":"Department fo Cancer and Genomics, University of Birmingham College of Medical and Dental Sciences, Birmingham, UK"},{"name":"Pan Birmingham Gynaecological Cancer Centre, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Crisp","sequence":"additional","affiliation":[{"name":"Crisp Quality Improvement Consultancy Limited, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5464-1944","authenticated-orcid":false,"given":"Carole","family":"Cummins","sequence":"additional","affiliation":[{"name":"Applied Health Sciences, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarada","family":"Kannangara","sequence":"additional","affiliation":[{"name":"Pan Birmingham Gynaecological Cancer Centre, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grisham","family":"Smotra","sequence":"additional","affiliation":[{"name":"Walsall Healthcare NHS Trust, Walsall, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Becky","family":"Tarbuck","sequence":"additional","affiliation":[{"name":"Pan Birmingham Gynaecological Cancer Centre, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omiete","family":"Duke","sequence":"additional","affiliation":[{"name":"Pan Birmingham Gynaecological Cancer Centre, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aamena","family":"Salar","sequence":"additional","affiliation":[{"name":"Modality Partnership, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Jhita","sequence":"additional","affiliation":[{"name":"Modality Partnership, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Sai","sequence":"additional","affiliation":[{"name":"Modality Partnership, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naresh","family":"Rati","sequence":"additional","affiliation":[{"name":"Modality Partnership, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5843-3015","authenticated-orcid":false,"given":"Sudha","family":"Sundar","sequence":"additional","affiliation":[{"name":"Department fo Cancer and Genomics, University of Birmingham College of Medical and Dental Sciences, Birmingham, UK"},{"name":"Pan Birmingham Gynaecological Cancer Centre, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"2026090204450825000_15.2.e003909.1","unstructured":"Ovarian cancer statistics. Cancer Research UK. Available: https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/ovarian-cancer [Accessed 05 May 2025]."},{"key":"2026090204450825000_15.2.e003909.2","unstructured":"National Cancer Audit Collaborating Centre . NOCA state of the nation report 2024. Available: https:\/\/www.natcan.org.uk\/reports\/noca-state-of-the-nation-report-2024\/ [Accessed 18 Mar 2025]."},{"key":"2026090204450825000_15.2.e003909.3","article-title":"Centralisation of services for gynaecological cancer","volume":"2012","author":"Woo","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"2026090204450825000_15.2.e003909.4","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/j.1471-0528.2007.01460.x","article-title":"Centralisation of services for the management of ovarian cancer: arguments for","volume":"114","author":"Olaitan","year":"2007","journal-title":"BJOG"},{"key":"2026090204450825000_15.2.e003909.5","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-3248"},{"key":"2026090204450825000_15.2.e003909.6","unstructured":"Overview | Ovarian cancer: recognition and initial management | Guidance. NICE. Available: https:\/\/www.nice.org.uk\/Guidance\/CG122 [Accessed 04 May 2025]."},{"key":"2026090204450825000_15.2.e003909.7","unstructured":"NHS cancer programme: faster diagnosis framework. Available: https:\/\/www.england.nhs.uk\/wp-content\/uploads\/2019\/07\/B1332-NHS-Cancer-Programme-Faster-Diagnosis-Framework-v5.pdf [Accessed 14 Jul 2025]."},{"key":"2026090204450825000_15.2.e003909.8","unstructured":"RCOG . Ovarian cysts in postmenopausal women (green-top guideline no.34). Available: https:\/\/www.rcog.org.uk\/guidance\/browse-all-guidance\/green-top-guidelines\/ovarian-cysts-in-postmenopausal-women-green-top-guideline-no-34\/ [Accessed 22 Jul 2025]."},{"key":"2026090204450825000_15.2.e003909.9","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g5920","article-title":"Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study","volume":"349","author":"Van Calster","year":"2014","journal-title":"BMJ"},{"key":"2026090204450825000_15.2.e003909.10","doi-asserted-by":"crossref","DOI":"10.1136\/bmjmed-2023-000817","article-title":"ADNEX risk prediction model for diagnosis of ovarian cancer: systematic review and meta-analysis of external validation studies","volume":"3","author":"Barre\u00f1ada","year":"2024","journal-title":"BMJ Med"},{"key":"2026090204450825000_15.2.e003909.11","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(24)00406-6"},{"key":"2026090204450825000_15.2.e003909.12","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-083912","article-title":"Diagnostic tests for ovarian cancer in premenopausal women with non-specific symptoms (ROCkeTS): prospective, multicentre, cohort study","volume":"392","author":"Sundar","year":"2026","journal-title":"BMJ"},{"key":"2026090204450825000_15.2.e003909.13","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2021-002565"},{"key":"2026090204450825000_15.2.e003909.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2024.06.025"},{"key":"2026090204450825000_15.2.e003909.15","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/uog.26080","article-title":"Benign descriptors and ADNEX in two-step strategy to estimate risk of malignancy in ovarian tumors: retrospective validation in IOTA5 multicenter cohort","volume":"61","author":"Landolfo","year":"2023","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2026090204450825000_15.2.e003909.16","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30837-4"},{"key":"2026090204450825000_15.2.e003909.17","doi-asserted-by":"publisher","DOI":"10.1177\/003693300404900413"},{"key":"2026090204450825000_15.2.e003909.18","first-page":"101","article-title":"One-stop hysteroscopy clinic for postmenopausal bleeding","volume":"50","author":"Lotfallah","year":"2005","journal-title":"J Reprod Med"},{"key":"2026090204450825000_15.2.e003909.19","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ejogrb.2023.09.018","article-title":"Current uptake and barriers to wider use of the International Ovarian Tumor Analysis (IOTA) models in Dutch gynaecological practice","volume":"291","author":"Lems","year":"2023","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2026090204450825000_15.2.e003909.20","doi-asserted-by":"publisher","DOI":"10.1055\/s-0030-1263214"},{"key":"2026090204450825000_15.2.e003909.21","unstructured":"Clinical decision support. Gynaia. Available: https:\/\/gynaia.com\/apps\/ [Accessed 19 Sep 2025]."},{"key":"2026090204450825000_15.2.e003909.22","doi-asserted-by":"publisher","DOI":"10.1191\/1478088706qp063oa"},{"key":"2026090204450825000_15.2.e003909.23","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15133335","article-title":"Evaluating the Harms of Cancer Testing-A Systematic Review of the Adverse Psychological Correlates of Testing for Cancer and the Effectiveness of Interventions to Mitigate These","volume":"15","author":"Kwong","year":"2023","journal-title":"Cancers (Basel)"},{"key":"2026090204450825000_15.2.e003909.24","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/j.1471-0528.2012.03297.x","article-title":"Triaging women with ovarian masses for surgery: observational diagnostic study to compare RCOG guidelines with an International Ovarian Tumour Analysis (IOTA) group protocol","volume":"119","author":"Van Calster","year":"2012","journal-title":"BJOG"},{"key":"2026090204450825000_15.2.e003909.25","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2017.17"},{"key":"2026090204450825000_15.2.e003909.26","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/1471-0528.70074","article-title":"A Cost Consequence Analysis of Seven Diagnostic Strategies for Ovarian Cancer: A Model\u2010Based Economic Evaluation","volume":"133","author":"Perry","year":"2026","journal-title":"BJOG"}],"container-title":["BMJ Open Quality"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjoq-2025-003909","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:45:16Z","timestamp":1788349516000},"score":1,"resource":{"primary":{"URL":"https:\/\/qir.bmj.com\/lookup\/doi\/10.1136\/bmjoq-2025-003909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":26,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,4,20]]},"published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.1136\/bmjoq-2025-003909"],"URL":"https:\/\/doi.org\/10.1136\/bmjoq-2025-003909","relation":{},"ISSN":["2399-6641"],"issn-type":[{"value":"2399-6641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]}}}